Mirae Asset Global Investments Co., Ltd. Supernus Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,868 shares of SUPN stock, worth $60,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,868
Previous 1,840
1.52%
Holding current value
$60,056
Previous $66,000
7.58%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$334 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$198 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$167 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$93.4 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$86.8 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.72B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...